N M Hula Selected Research

N-stearoylethanolamine

1/2015	The effect of N-stearoylethanolamine on plasma lipid composition in rats with experimental insulin resistance.
11/2014	The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin resistance.
5/2014	[N-stearoylethanolamine effect on the level of 11-hydroxycorticosteroids, cytokines IL-1, IL-6 and TNFalpha in rats with nonspecific inflammation caused by thermal burn of skin].
1/2014	[The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity].
9/2013	[The effect of N-stearoylethanolamine on the activity of antioxidant enzymes, content of lipid peroxidation products and nitric oxide in the blood plasma and liver of rats with induced insulin-resistance].
3/2013	[Organ-specific antitoxic effects of N-stearoylethanolamine in male mice with Lewis carcinoma under doxorubicin intoxication].
7/2012	[Protective effect of N-stearoylethanolamine in suspension and in nanocomposite complex in the organs of mice with the Lewis carcinoma under doxorubicin intoxication administration].
5/2010	[The modelling of N-stearoylethanolamine effect of 17beta-estradiol in the organism of male rats].
3/2010	[Protective effect of N-stearoylethanolamine in acute alcohol intoxication in rats].
3/2009	[Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N M Hula Research Topics

Disease

10	Body Weight (Weight, Body) 11/2014 - 09/2007
5	Carcinoma (Carcinomatosis) 09/2013 - 01/2006
4	Insulin Resistance 01/2015 - 09/2013
4	Obesity 01/2015 - 01/2003
4	Neoplasms (Cancer) 09/2013 - 01/2006
4	Ischemia 03/2002 - 01/2000
3	Wounds and Injuries (Trauma) 05/2014 - 07/2000
3	Morphine Dependence 03/2005 - 09/2004
2	Burns 05/2014 - 03/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2008 - 11/2001
2	Neoplasm Metastasis (Metastasis) 03/2006 - 01/2006
2	Hypertension (High Blood Pressure) 01/2002 - 01/2001
1	Fatty Liver 11/2014
1	Inflammation (Inflammations) 05/2014
1	Lewis Lung Carcinoma 09/2013
1	Necrosis 07/2012
1	Premature Cardiac Complexes (Extrasystoles) 05/2008
1	Contact Dermatitis (Eczema, Contact) 01/2008
1	Anaphylaxis (Anaphylactic Shock) 01/2008
1	Hypersensitivity (Allergy) 01/2008
1	Essential Hypertension 01/2002
1	Myocardial Infarction 11/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2001

Drug/Important Bio-Agent (IBA)

14	N-stearoylethanolamineIBA 01/2015 - 01/2006
11	LipidsIBA 01/2015 - 01/2000
8	Fatty Acids (Saturated Fatty Acids)IBA 11/2014 - 01/2001
8	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014 - 01/2001
6	SuspensionsIBA 05/2014 - 11/2007
5	N-acylethanolaminesIBA 05/2014 - 01/2000
5	AntioxidantsIBA 09/2013 - 03/2006
4	CholesterolIBA 11/2014 - 01/2006
4	CatalaseIBA 09/2013 - 03/2006
4	EnzymesIBA 09/2013 - 09/2007
3	CytokinesIBA 01/2015 - 03/2009
3	Cholesterol Esters (Cholesteryl Esters)IBA 11/2014 - 01/2001
3	Streptozocin (Streptozotocin)FDA Link 11/2014 - 09/2007
3	Superoxide DismutaseIBA 09/2013 - 03/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2013 - 07/2012
3	Neuroprotective AgentsIBA 03/2005 - 09/2004
2	Nonesterified Fatty Acids (NEFA)IBA 01/2015 - 11/2014
2	AcidsIBA 11/2014 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 09/2007
2	11-HydroxycorticosteroidsIBA 05/2014 - 05/2010
2	Glutathione PeroxidaseIBA 09/2013 - 03/2013
2	Urea (Carbamide)FDA LinkGeneric 07/2012 - 01/2001
2	EndocannabinoidsIBA 03/2009 - 01/2008
2	Phosphatidylcholines (Phosphatidylcholine)IBA 09/2007 - 01/2006
2	Morphine (MS Contin)FDA LinkGeneric 09/2007 - 09/2004
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2006 - 01/2006
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 03/2006 - 01/2006
2	phosphatidylethanolamineIBA 03/2002 - 01/2000
2	Angiotensin IIIBA 01/2002 - 01/2002
2	ArginaseIBA 01/2002 - 01/2001
2	Irbesartan FDA LinkGeneric 01/2002 - 01/2002
2	Arginine (L-Arginine)FDA Link 01/2002 - 01/2001
1	FatsIBA 01/2015
1	Lipoproteins (Lipoprotein)IBA 01/2015
1	Monounsaturated Fatty AcidsIBA 11/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014
1	Interleukin-1 (Interleukin 1)IBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	Insulin (Novolin)FDA Link 01/2014
1	CreatinineIBA 09/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2012
1	Testosterone (Sustanon)FDA Link 05/2010
1	LysophospholipidsIBA 05/2008
1	Dinitrochlorobenzene (DNCB)IBA 01/2008
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2008
1	Thiobarbituric Acid Reactive SubstancesIBA 09/2007
1	SphingosineIBA 01/2006
1	PhosphatidylserinesIBA 01/2006
1	CatecholaminesIBA 01/2005
1	Dopamine (Intropin)FDA LinkGeneric 01/2005
1	essential 303 forteIBA 09/2004
1	AnionsIBA 01/2003
1	Cardiolipins (Cardiolipin)IBA 03/2002
1	EicosanoidsIBA 01/2002
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2002
1	Leukotriene C4IBA 01/2002
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2001
1	palmidrolIBA 01/2001
1	Antihypertensive Agents (Antihypertensives)IBA 01/2001

Therapy/Procedure

1	Oral Administration 01/2002